BiomaterialsMoney & FundingRegenerative Medicine

Dimension Inx receives grant to develop a regenerative medical product for tracheal repair

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Dimension Inx, a regenerative biomaterials company, has been awarded funding from the United States Department of Defense to develop innovative products to repair tracheal injuries. The $240,000 award will support the initial development of a new tracheal implant solution that overcomes current limitations and can be readily applied for emergency treatment as well as restoration of long-term patient health.

This project leverages Dimension Inx’s patented biomaterials platform for creating implantable constructs that emulate the complex microenvironment of the trachea. The constructs will be combined with a novel hydrogel to further support effective remodeling into normally functioning tracheal tissue. “Our technology platform allows us to create unique, microstructurally-driven materials and structures that account for the complex multi-tissue environment of the trachea,” said Dr. Adam Jakus, Dimension Inx Chief Technology Officer and principal investigator for this project. “This is critical for promoting healthy tissue regeneration and restoring the original tissue functions.”

Dimension Inx awarded grant to develop regenerative medical product for tracheal repair
Dr. Ramille Shah and Dr. Adam Jakus, two of Dimension Inx’s Co-founders and inventors of Dimension’s platform technology, in the Chicago lab. Dr. Shah is handling a jar of Hyperelastic Bone; Dr. Jakus is handling a 3D printed structure (in the shape of a pelvis) made of Hyperelastic Bone.

Tracheal injuries, such as those affecting military warfighters, can be immediately life-threatening, compromising the ability to breathe and requiring emergency stabilization. Current emergency treatment options are severely limited, and even with successful stabilization, long-term comprehensive medical treatment is often required to maintain patient health. Surgical approaches to treat tracheal defects are complex with up to 80% mortality, in large part due to the limited efficacy of implant options.

“Tissue engineering and cell therapy hold promise for providing much-needed solutions for these patients,” said Daniel Weiss, M.D., Ph.D., Professor of Medicine in the Pulmonary and Critical Care Division of the Department of Medicine at the University of Vermont and project co-investigator. “This award will advance our early work toward addressing a significant unmet medical problem.”

The 18-month project aims to also lay the groundwork for a new approach for creating multi-tissue regenerative structures for broader soft tissue applications, including esophagus, larynx, and facial cartilage repair.

Research 2021
Ceramic AM Market Opportunities and Trends

This market study from 3dpbm Research provides an in-depth analysis and forecast of the ceramic additive ma...

Andrea Gambini

Andrea has always loved reading and writing. He started working in an editorial office as a sports journalist in 2008, then the passion for journalism and for the world of communication in general, allowed him to greatly expand his interests, leading to several years of collaborations with several popular online newspapers. Andrea then approached 3D printing, impressed by the great potential of this new technology, which day after the day pushed him to learn more and more about what he considers a real revolution that will soon be felt in many fields of our daily life.

Related Articles

Back to top button

We use cookies to give you the best online experience and for ads personalisation. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services



Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*